GlassScriptPhysician profile
Carl Michael Erickson
NPI 1710970876
$14,063.82
in general payments reported to CMS, 2019-2025
64 companies · $2,037 in 2025
The $2,037 reported for 2025 was more than what 96% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,155 · 2020: $2,289 · 2021: $2,127 · 2022: $1,844 · 2023: $1,786 · 2024: $1,826 · 2025: $2,037.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,611 · Education: $38.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,610.99 |
| Education | $38.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,940.01 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,464.49 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $828.52 | 2019-2025 | Rexulti, Abilify Maintena, Abilify Asimtufii |
| Pfizer INC. | $818.36 | 2019-2025 | |
| Lilly USA, LLC | $729.17 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $708.74 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $497.89 | 2019-2022 | |
| Allergan, INC. | $462.62 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $458.16 | 2022-2025 | |
| Aimmune Therapeutics, INC. | $426.80 | 2024-2025 | Zenpep, Vowst |
| Nestle Healthcare Nutrition INC. | $405.92 | 2020-2022 | |
| Amgen INC. | $395.72 | 2019-2025 | Repatha, Otezla, Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $331.38 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $303.95 | 2019-2025 | Xifaxan |
| Grifols USA, LLC | $288.54 | 2019-2023 | Prolastin-C Liquid |
Show all 64 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $250.48 | 2019-2025 | Belsomra, M-M-R II, Gardasil 9 |
| Exact Sciences Corporation | $239.42 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $206.36 | 2019-2023 | |
| Lundbeck LLC | $174.05 | 2020-2025 | Rexulti |
| Glaxosmithkline, LLC. | $172.10 | 2019-2025 | Trelegy Ellipta |
| Biohaven Pharmaceutical Holding Company LTD. | $161.84 | 2022 | |
| Indivior INC. | $159.06 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $156.05 | 2019-2025 | Austedo Xr |
| Alkermes, INC. | $143.43 | 2022-2023 | Lybalvi |
| Biohaven Pharmaceuticals, INC. | $136.65 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $129.70 | 2019-2024 | Trintellix |
| E.R. Squibb & Sons, L.L.C. | $123.21 | 2019-2024 | Eliquis |
| Collegium Pharmaceutical, INC. | $121.54 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $118.75 | 2019-2025 | Zoryve, Livalo, Seglentis |
| Phathom Pharmaceuticals, INC. | $117.42 | 2024-2025 | Voquezna |
| Edwards Lifesciences Corporation | $108.89 | 2023-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Antares Pharma, INC. | $108.18 | 2020-2024 | Xyosted, Tlando, Nocdurna |
| Janssen Pharmaceuticals, INC | $105.58 | 2021-2024 | Spravato |
| Jazz Pharmaceuticals INC. | $104.31 | 2019-2021 | |
| Daiichi Sankyo INC. | $99.75 | 2019-2022 | |
| Mdd US Operations, LLC | $79.99 | 2019 | |
| Axsome Therapeutics, INC. | $72.86 | 2023 | Sunosi |
| Halozyme INC | $69.08 | 2023 | |
| Eisai INC. | $68.41 | 2020-2021 | |
| Boston Scientific Corporation | $66.05 | 2020-2025 | Cds - Mct/Cem Monitoring |
| Biodelivery Sciences International, INC. | $52.69 | 2019-2021 | |
| Corcept Therapeutics | $51.12 | 2025 | Korlym |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $46.67 | 2025 | Caplyta |
| Corium, LLC | $45.26 | 2023 | Azstarys |
| Medtronic, INC. | $45.24 | 2021 | |
| Nevro Corp. | $39.94 | 2020-2021 | |
| Azurity Pharmaceuticals, INC. | $37.96 | 2023-2024 | Horizant, Horizant |
| Arbor Pharmaceuticals, INC. | $35.53 | 2019-2021 | |
| Medtronic Vascular, INC. | $35.16 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $32.03 | 2025 | Gemtesa |
| Horizon Therapeutics Plc | $31.32 | 2022 | |
| Harmony Biosciences LLC | $29.63 | 2023 | Wakix |
| Sunovion Pharmaceuticals INC. | $25.19 | 2022 | |
| Alexion Pharmaceuticals, INC. | $23.55 | 2023 | Strensiq |
| Therapeuticsmd, INC. | $23.15 | 2021 | |
| Alfasigma USA, INC. | $23.05 | 2020 | |
| Teleflex LLC | $21.64 | 2023 | Urolift |
| Lucid Diagnostics INC. | $20.11 | 2022 | |
| Shire North American Group INC | $18.70 | 2019 | |
| Idorsia Pharmaceuticals US INC | $17.11 | 2025 | Quviviq |
| Gilead Sciences, INC. | $16.61 | 2025 | |
| Scilex Pharmaceuticals INC. | $13.68 | 2019 | |
| Astellas Pharma US INC | $13.38 | 2020 | |
| Clarus Therapeutics INC. | $11.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carl Erickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.